Has Khurram Wadud, MD received payments from drug or device companies?

Yes. Drug and device makers reported $337,942 in general payments to Khurram Wadud, MD across 1,982 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Khurram Wadud, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Khurram Wadud, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Khurram Wadud, MD

Endocrinology, Diabetes & Metabolism · Jacksonville, FLNPI 1801877576

Payments from drug & device makers

$337,942in general payments, 2019–2025

Across 1,982 payments — averaging $170.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk AS$259K
Bayer$29K
AstraZeneca$27K
Novo Nordisk$4K
Janssen Research & Development, LLC$2K
Abbott$2K
plus $15K from 46 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk AS	885	$258,510
Bayer	41	$28,605
AstraZeneca(2 entities)	72	$27,485
Novo Nordisk	184	$4,174
Janssen Research & Development, LLC	1	$2,495
Abbott	124	$1,960
Medtronic(2 entities)	35	$1,499
Sanofi-aventis U.S. LLC	68	$1,394
Insulet Corporation	63	$1,336
Lilly USA, LLC	69	$1,288
Amgen(2 entities)	55	$1,220
Boehringer Ingelheim	55	$966
Dexcom, Inc.	42	$932
Amneal Pharmaceuticals LLC	40	$715
Mannkind Corporation	19	$660
Xeris Pharmaceuticals, Inc.	32	$636
Radius Health, Inc.	25	$547
Corcept Therapeutics	20	$401
Antares Pharma, Inc.	21	$399
AbbVie	21	$375
IBSA Pharma Inc.	21	$346
Cequr Corporation	2	$254
Sequel Med Tech, LLC	6	$223
Endo Pharmaceuticals Inc.	14	$183
Tandem Diabetes Care, Inc.	9	$182
Merck	9	$135
Astellas Pharma US Inc	7	$129
Ascensia Diabetes Care US Inc.	5	$107
Neurocrine Biosciences, Inc.	3	$81
Valeritas, Inc.	1	$79
BETA Bionics, Inc.	2	$52
Azurity Pharmaceuticals, Inc.	2	$47
Lifescan, Inc.	3	$43
Acella Pharmaceuticals, LLC	2	$42
Boston Scientific	2	$37
Halozyme Inc	2	$35
Novartis	2	$33
Rhythm Pharmaceuticals, Inc.	1	$30
Madrigal Pharmaceuticals	1	$30
Currax Pharmaceuticals LLC	2	$28
Johnson & Johnson	2	$27
Shire North American Group Inc	2	$27
Globus Medical	1	$26
Zealand Pharma US, Inc.	1	$25
GRT US Holding, Inc.	1	$24
Recordati_rare_diseases_inc.	1	$23
Senseonics, Incorporated	1	$21
GSK	1	$19
Ultragenyx Pharmaceutical Inc.	1	$17
Kyowa Kirin, Inc.	1	$14
Ipsen Biopharmaceuticals, Inc	1	$14
Acerus Pharmaceuticals Corporation	1	$14

How this compares

$337,942 in reported general payments places this provider in the 90th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida →

Medicare billing

Part B allowed, 2024

$308,587

Medicare patients

987

Services billed

5,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Jacksonville

David SuttonJacksonville$3.1M
Mae Sheikh AliJacksonville$2.9M
James MageeJacksonville$2.7M
Senan SultanJacksonville$2.5M
J EvansJacksonville$1.7M
Wasim DeebJacksonville$1.5M
Ricardo SilvaJacksonville$867K
Anil ShresthaJacksonville$602K
Joe ChehadeJacksonville$542K
Firas WardaJacksonville$440K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →